Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model

This study aimed to investigate the role of vascular insulin resistance (VIR) and Tribbles homolog 3 (TRIB3) in the pathogenesis of hypoxia-induced pulmonary hypertension (HPH). Rats were subjected to low air pressure and low oxygen intermittently for 4 weeks to induce HPH. The mean right ventricula...

Full description

Bibliographic Details
Main Authors: Fang Fan, Jinxiao He, Hui Su, Haifeng Zhang, Hao Wang, Qianqian Dong, Minghua Zeng, Wenjuan Xing, Xin Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2020.542146/full
id doaj-90e716e5ab064144b29248aadbf19503
record_format Article
spelling doaj-90e716e5ab064144b29248aadbf195032020-11-25T03:36:38ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2020-10-011110.3389/fphys.2020.542146542146Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat ModelFang Fan0Jinxiao He1Hui Su2Haifeng Zhang3Hao Wang4Qianqian Dong5Minghua Zeng6Wenjuan Xing7Wenjuan Xing8Xin Sun9Department of Pediatrics, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Pediatrics, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Geratology, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaTeaching Experiment Center, Fourth Military Medical University, Xi’an, ChinaDepartment of Pediatrics, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Natural Medicine, School of Pharmacy, Fourth Military Medical University, Xi’an, ChinaDepartment of Pediatrics, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaSchool of Aerospace Medicine, Fourth Military Medical University, Xi’an, ChinaState Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, ChinaDepartment of Pediatrics, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaThis study aimed to investigate the role of vascular insulin resistance (VIR) and Tribbles homolog 3 (TRIB3) in the pathogenesis of hypoxia-induced pulmonary hypertension (HPH). Rats were subjected to low air pressure and low oxygen intermittently for 4 weeks to induce HPH. The mean right ventricular pressure (mRVP), mean pulmonary arterial pressure (mPAP), and right ventricular index (RVI) were significantly increased in HPH rats. Pulmonary arteries from HPH rats showed VIR with reduced vasodilating effect of insulin. The protein levels of peroxisome proliferator-activated receptor gamma (PPARγ), phosphoinositide 3-kinase (PI3K), phosphorylations of Akt, and endothelial nitric oxide (NO) synthase (eNOS) were decreased, and TRIB3 and phosphorylated extracellular signal-regulated protein kinases (ERK1/2) were increased in pulmonary arteries of HPH rats. Early treatment of pioglitazone (PIO) partially reversed the development of HPH, improved insulin-induced vasodilation, and alleviated the imbalance of the insulin signaling. The overexpression of TRIB3 in rat pulmonary arterial endothelial cells (PAECs) reduced the levels of PPARγ, PI3K, phosphorylated Akt (p-Akt), and phosphorylated eNOS (p-eNOS) and increased p-ERK1/2 and the synthesis of endothelin-1 (ET-1), which were further intensified under hypoxic conditions. Moreover, TRIB3 knockdown caused significant improvement in Akt and eNOS phosphorylations and, otherwise, a reduction of ERK1/2 activation in PAECs after hypoxia. In conclusion, impaired insulin-induced pulmonary vasodilation and the imbalance of insulin-induced signaling mediated by TRIB3 upregulation in the endothelium contribute to the development of HPH. Early PIO treatment improves vascular insulin sensitivity that may help to limit the progression of hypoxic pulmonary hypertension.https://www.frontiersin.org/articles/10.3389/fphys.2020.542146/fullhypoxic pulmonary hypertensionproliferator-activated receptor gammapulmonary arterial endotheliumvascular insulin resistanceTribbles homolog 3
collection DOAJ
language English
format Article
sources DOAJ
author Fang Fan
Jinxiao He
Hui Su
Haifeng Zhang
Hao Wang
Qianqian Dong
Minghua Zeng
Wenjuan Xing
Wenjuan Xing
Xin Sun
spellingShingle Fang Fan
Jinxiao He
Hui Su
Haifeng Zhang
Hao Wang
Qianqian Dong
Minghua Zeng
Wenjuan Xing
Wenjuan Xing
Xin Sun
Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
Frontiers in Physiology
hypoxic pulmonary hypertension
proliferator-activated receptor gamma
pulmonary arterial endothelium
vascular insulin resistance
Tribbles homolog 3
author_facet Fang Fan
Jinxiao He
Hui Su
Haifeng Zhang
Hao Wang
Qianqian Dong
Minghua Zeng
Wenjuan Xing
Wenjuan Xing
Xin Sun
author_sort Fang Fan
title Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
title_short Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
title_full Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
title_fullStr Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
title_full_unstemmed Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
title_sort tribbles homolog 3-mediated vascular insulin resistance contributes to hypoxic pulmonary hypertension in intermittent hypoxia rat model
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2020-10-01
description This study aimed to investigate the role of vascular insulin resistance (VIR) and Tribbles homolog 3 (TRIB3) in the pathogenesis of hypoxia-induced pulmonary hypertension (HPH). Rats were subjected to low air pressure and low oxygen intermittently for 4 weeks to induce HPH. The mean right ventricular pressure (mRVP), mean pulmonary arterial pressure (mPAP), and right ventricular index (RVI) were significantly increased in HPH rats. Pulmonary arteries from HPH rats showed VIR with reduced vasodilating effect of insulin. The protein levels of peroxisome proliferator-activated receptor gamma (PPARγ), phosphoinositide 3-kinase (PI3K), phosphorylations of Akt, and endothelial nitric oxide (NO) synthase (eNOS) were decreased, and TRIB3 and phosphorylated extracellular signal-regulated protein kinases (ERK1/2) were increased in pulmonary arteries of HPH rats. Early treatment of pioglitazone (PIO) partially reversed the development of HPH, improved insulin-induced vasodilation, and alleviated the imbalance of the insulin signaling. The overexpression of TRIB3 in rat pulmonary arterial endothelial cells (PAECs) reduced the levels of PPARγ, PI3K, phosphorylated Akt (p-Akt), and phosphorylated eNOS (p-eNOS) and increased p-ERK1/2 and the synthesis of endothelin-1 (ET-1), which were further intensified under hypoxic conditions. Moreover, TRIB3 knockdown caused significant improvement in Akt and eNOS phosphorylations and, otherwise, a reduction of ERK1/2 activation in PAECs after hypoxia. In conclusion, impaired insulin-induced pulmonary vasodilation and the imbalance of insulin-induced signaling mediated by TRIB3 upregulation in the endothelium contribute to the development of HPH. Early PIO treatment improves vascular insulin sensitivity that may help to limit the progression of hypoxic pulmonary hypertension.
topic hypoxic pulmonary hypertension
proliferator-activated receptor gamma
pulmonary arterial endothelium
vascular insulin resistance
Tribbles homolog 3
url https://www.frontiersin.org/articles/10.3389/fphys.2020.542146/full
work_keys_str_mv AT fangfan tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT jinxiaohe tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT huisu tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT haifengzhang tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT haowang tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT qianqiandong tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT minghuazeng tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT wenjuanxing tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT wenjuanxing tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
AT xinsun tribbleshomolog3mediatedvascularinsulinresistancecontributestohypoxicpulmonaryhypertensioninintermittenthypoxiaratmodel
_version_ 1724549013070413824